Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-25T01:28:46.820Z Has data issue: false hasContentIssue false
  • English
  • Français

Attenuation of learned helplessness in rats after transplant of adrenal medulla into the spinal cord

Published online by Cambridge University Press:  16 April 2020

P Tejedor-Real ,
JA Micó ,
JP Corbalan ,
I Ruz-Franzi ,
JM González-Darder  and
J Gibert-Rahola
P Tejedor-Real
Affiliation:
Department of Neurosciences, School of Medicine, University of Cádiz, Plaza Fragela s/n, 11003Cádiz, Spain
JA Micó
Affiliation:
Department of Neurosciences, School of Medicine, University of Cádiz, Plaza Fragela s/n, 11003Cádiz, Spain
JP Corbalan
Affiliation:
Department of Neurosciences, School of Medicine, University of Cádiz, Plaza Fragela s/n, 11003Cádiz, Spain
I Ruz-Franzi
Affiliation:
Department of Neurosciences, School of Medicine, University of Cádiz, Plaza Fragela s/n, 11003Cádiz, Spain
JM González-Darder
Affiliation:
Department of Neurosciences, School of Medicine, University of Cádiz, Plaza Fragela s/n, 11003Cádiz, Spain
J Gibert-Rahola
Affiliation:
Department of Neurosciences, School of Medicine, University of Cádiz, Plaza Fragela s/n, 11003Cádiz, Spain
Get access

Summary

The influence of an adrenal medullary transplant into the lumbar subarachnoid space on learned helplessness, an animal model of depression, was examined. The transplanted rats were found to be less susceptible than sham-operated animals to become helpless after administration of inescapable shocks. The effect was attributed to release of opioid peptides by chromaffin cells as it was reversed by naloxone. The viability of the transplanted tissue was verified by electron microscopy.

Keywords

adrenal medullary transplantopioid peptidesnaloxonelearned helplessnessdepressionrat
Type
Original article
Information
European Psychiatry , Volume 11 , Issue 5 , 1996 , pp. 249 - 253
Copyright
Copyright © Elsevier, Paris 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anisman, HSuissa, ASklar, LSEscape deficits induced by uncontrollable stress: antagonism by dopamine and norepinephrine agonists Behav Neural Biol 1980; 28: 3444–3474CrossRefGoogle ScholarPubMed
Bommer, NHerz, ANeuropeptides and other secretagogues in bovine chromaffin cells: their effect on opioid peptide metabolism Neuropeptides 1989; 13: 2443–2451CrossRefGoogle ScholarPubMed
Devoize, JLRigal, FEschalier, ATrolese, JFRenoux, MInfluence of naloxone on antidepressant drug effect in the forced-swimming test in mice Psychopharmacology 1984; 84: 71–75CrossRefGoogle ScholarPubMed
Extein, IPottash, ALCGold, MSA possible opioid receptor dysfunction in some depressive disorders In: Verebey, K eds. Opioids in Mental Illness: Theory, Clinical Observations, and Treatment Possibilities New York: The New York Academy of Sciences, 1982; 108–112Google Scholar
Gaumann, DMYaksh, TLEffects and opiate antagonists on adrenal release of neuropeptides in cats Peptides 1988; 9: 393–405CrossRefGoogle ScholarPubMed
Guide for the Care and Use of Laboratory Animals. US Department of Health, Education and Welfare, Public health service National Institute of Health, DHEW Publication NO (NIH) 78-23 Revised 1978Google Scholar
Hamon, MGozlan, HBourgoin, S, et al.Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline Neuropharmacology 26 1987 531–539CrossRefGoogle ScholarPubMed
Isemberg, KECicero, TPossible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds Eur J Pharmacol 1984; 103: 57–63CrossRefGoogle Scholar
Kuramoto, HKondo, HFujita, TCalcitonine gene-related peptide (CGPR)-like immunoreactivity in scattered chromaffin cells and nerve fibers in the adrenal gland Cell Tissue Res 1987; 247: 309–315CrossRefGoogle Scholar
Linberg, IYang, HYTDistribution of met (5)-enk-arg (6) gly (7)-leu (8)-immunoreactive peptides in rat brain: presence of multiple molecular form Brain Res 1984; 299: 73–78CrossRefGoogle Scholar
Livett, BGDean, DMWhelan, LGUdenfriend, SRossier, JCo-release of enkephalin and catecholamines from cultured adrenal chromaffin cells Nature 1981; 289: 317–319CrossRefGoogle ScholarPubMed
Martin, PSoubrié, PSimon, PNoradrenergic and opioid mediation of tricyclic-induced reversal of escape deficits caused by inescapable shock pretreatment in rats Psychopharmacology (Berlin) 1986; 90: 90–94CrossRefGoogle ScholarPubMed
Martin, PSoubrié, PSimon, PShuttlebox deficits induced by inescapable shocks in rats: Reversal by the beta-adrenoceptor stimulants clenbuteron and salbutamol Pharmacol Biochem Behav 1986; 24: 177–181CrossRefGoogle Scholar
Naber, DOpioids on the etiology and treatment of psychiatric disorders In: Herz, A eds. Opioid II Berlin, Heidelberg: Springer-Verlag, 1993; 781–801CrossRefGoogle Scholar
Ortega, JDSagen, JPharmacologic characterization of opioid peptide release from chromaffin cell transplants using a brain slice superfusion method J Exp Brain Res 1993; 95: 381–387Google ScholarPubMed
Ortega-Alvaro, AGibert-Rahola, JChover, AJTejedro-Real, PCasa, JMicó, JAEffect of amitriptyline on the analgesia induced by adrenal medullary tissue transplanted in the rat spinal subarachnoid space as measured by an experimental model of acute pain Exp Neurol 1994; 130: 9–14CrossRefGoogle ScholarPubMed
Petty, FSherman, ADReversal of learned helplessness by imipramine Community Psychopharmacol 1980; 3: 371–373Google Scholar
Ruz-Franzi, JIGonzález-Darder, JMStudy of the analgesic effects of the implant of adrenal medullary into the subarachnoid space in rats Acta Neurochir (Wein) 1991; 52:suppl 39–41CrossRefGoogle ScholarPubMed
Sagen, JPappas, GDPollard, HBAdrenal medullary tissue transplants in rat spinal cord reduce pain sensitivity Brain Res 1986 384–389Google ScholarPubMed
Sagen, JPappas, GDPollard, HBAnalgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord Proc Natl Acad Sci USA 1986; 83 7522CrossRefGoogle ScholarPubMed
Sagen, JKemmler, EIncreased levels of met-enkephalin-like immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplant Brain Res 1989; 502: 1–10CrossRefGoogle Scholar
Sagen, JWang, HProlonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplant Eur J Pharmacol 1990; 179: 427–433CrossRefGoogle Scholar
Sagen, JSortwell, CEPappas, GDMonoaminergic neural transplant prevent learned helplessness in a rat depression model Biol Psychiatry 1990; 28: 1037–1047CrossRefGoogle Scholar
Sagen, JKemmler, JEWang, HAdrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity J Neurochem 1991; 56: 623–627CrossRefGoogle ScholarPubMed
Sawynok, JPinsky, CLaBella, FSMinireview on the specifity of naloxone as an opiate antagonist Life Sci 1979; 25: 1621–1632CrossRefGoogle Scholar
Sherman, ADPetty, FAdditivity of neurochemical changes in learned helplessness and imipramine Behav Neural Biol 1982; 35: 344–353CrossRefGoogle ScholarPubMed
Tejedor-Real, PMico, JAMaldonado, RRoques, BPGibert-Rahola, JEffect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat Biol Psychiatry 1993; 34: 100–107CrossRefGoogle ScholarPubMed
Tejedor-Real, PMicó, JAMaldonado, RRoques, BGibertRahola, JImplication of endogenous opioid system in the learned helplessness model of depression Pharmacol Biochem Behav 1995; 52: 145–152CrossRefGoogle ScholarPubMed
Tejedor-Real, PRomero, PMicó, JAGibert-Rahola, JEfecto del NPY en el modelo de depresón “learned helplessness”. Posible interacción con el sistema noradrenérgico Anales Psiquiatría Biológica 1994 10suppl 1 49Google Scholar
Vaquero, JArias, AOya, SantiagoZurita, MChromaffin allografts into arachnoid of spinal cord reduce basal pain responses in rats Neuroreport 1991; 2: 149–151CrossRefGoogle ScholarPubMed
Widerlöv, MDHeilig, MDBjartell, AEkman, RInvolvement of Neuropeptide Y and Delta-Sleep-Inducing Peptide in Neuropsychiatric Illness In: Nemeroff, CB eds. Neuropeptides and Psychiatric Disorders Washington DC: American Psychiatric Press, Inc, 1991; 227–260Google Scholar
Willner, PThe validity of animal models of depression Psychopharmacology 1984; 83: 1–16CrossRefGoogle ScholarPubMed
Willner, PBehavioral Models in Psychopharmacology, Theoretical, Industrial and Clinical Perspectives Cambridge: Cambridge University Press, 1990Google Scholar
Willson, SPChang, JViveros, OHProportional secretion of opioid peptides and catecholamines form adrenal cromaffin cells in culture J Neurosci 1982; 2: 1150–1156CrossRefGoogle Scholar
Yang, HTHexum, TCosta, EOpioid peptides in adrenal gland Life Sci 1980; 27: 1119–1125CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.